shares

PAVING THE WAY FOR WOMEN’S VOICES: ENTREPRENEUR SHAILI CHOPRA SHARES HER ADVICE FOR FEMALE FOUNDERS ON THE FOUNDERMETRICS PODCAST, BY VESTD

FROM BUSINESS REPORTER TO FOUNDING A WOMEN'S MOVEMENT: SHAILI CHOPRA'S JOURNEY TO BUILDING A SIX-MILLION STRONG COMMUNITYMUMBAI, India, Nov. 26,…

1 month ago

Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

November 21, 2025 16:30 ET  | Source: Conavi Medical Corp. PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+ NOT FOR RELEASE OR DISTRIBUTION…

1 month ago

Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract presentation November 16, 2025 01:02 ET  | Source:…

2 months ago

Jet.AIReports Third Quarter 2025 Financial Results and Shares Progress on the Third Milestone of the Canadian Hyperscale Data Center Project

LAS VEGAS, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Jet.AI. Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), an emerging leader in…

2 months ago

Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them

Company announcement no. 32 In accordance with Article 19 (3) of the Market Abuse Regulation, Columbus A/S is required to…

2 months ago

HYUNDAI MOTOR COMPANY PRESIDENT AND CEO JOS MUOZ SHARES STRATEGIC VISION FOR 2026 AT 2025 LEADERS TALK

Hyundai Motor CEO José Muñoz emphasised resilience, adaptability, and cross-functional alignment as key strengths to confidently lead future mobilityMuñoz shared…

2 months ago

Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares

MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced…

2 months ago

Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025

October 25, 2025 11:01 ET  | Source: Cullinan Therapeutics, Inc. CLN-978 led to rapid and deep B cell depletion in…

2 months ago

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million

SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing…

3 months ago

Idorsia successfully completes an upsized offering of shares funding the company to overall profitability

Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY,…

3 months ago